ArticleMolecular medicine reports2017

Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.

Ling-Jian Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.